Publication: The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
Loading...
Program
relationships.isAuthorOf
Author
Ozcelik, M.
Odabas, H.
Ercelep, O.
Yuksel, S.
Mert, A. G.
Aydin, D.
Surmeli, H.
Isik, D.
Isik, S.
Oyman, A.
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
The optimal treatment in older persons with metastatic colorectal cancer (mCRC) is complicated by a lack of general agreement. The aim of this study was to evaluate the activity of bevacizumab plus capecitabine combination in elderly mCRC patients who were not suitable for chemotherapy with irinotecan and oxaliplatin-containing regimens.
Description
Source
Keywords
Keywords
Citation
Ozcelik M., Odabas H., Ercelep O., Yuksel S., Mert A. G. , Aydin D., Surmeli H., Isik D., Isik S., Oyman A., et al., -The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients-, CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.18, ss.617-624, 2016